HIS
INDV icon

Harvest Investment Services’s Indivior Pharmaceuticals INDV Stock Holding History

Harvest Investment Services’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Sell
41,539
-3,305
-7% -$120K 0.26% 105
2026
Q1 		$1.37M Buy
44,844
+27,867
+164% +$920K 0.25% 102
2025
Q4 		$609K Buy
+16,977
New +$518K 0.11% 179

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Investment Services's INDV Position: Q2 2026 in Review

Harvest Investment Services reduced its Indivior Pharmaceuticals (INDV) stake by 7.4% in Q2 2026, selling an estimated $120K and leaving 41,539 shares worth $1.7M. The position accounts for 0.26% of the portfolio, ranked #105.

Harvest Investment Services first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Harvest Investment Services held 41,539 shares of Indivior Pharmaceuticals worth $1.7M as of Q2 2026.
  • Harvest Investment Services sold 3,305 Indivior Pharmaceuticals shares in Q2 2026, an estimated $120K.
  • Indivior Pharmaceuticals made up 0.26% of Harvest Investment Services's portfolio in Q2 2026, its #105 holding.
  • Harvest Investment Services first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Harvest Investment Services's 13F filing for Q2 2026, filed 14 Aug 2026.